Loading organizations...
Loading organizations...
Nasal drug delivery technologies for efficient medication administration.
OptiNose has raised $115.5M across 3 funding rounds.
OptiNose has raised $115.5M in total across 3 funding rounds.
OptiNose has raised $115.5M in total across 3 funding rounds.
OptiNose's investors include Fidelity Management & Research Company, Avista Capital Partners, Entrepreneurs Fund.
OptiNose has raised $115.5M across 3 funding rounds. Most recently, it raised $37.0M Series D in May 2017.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 9, 2017 | $37.0M Series D | Fidelity Management & Research Company | Avista Capital Partners, Entrepreneurs Fund |
| Oct 6, 2015 | $30.0M Other Equity | ||
| Jun 8, 2010 | $48.5M Other Equity | Avista Capital Partners |